• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • Virtual Data Room (VDR) for Strategic Customized Slide Decks
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Danielle Smolyar, PERSONAL PAGE on 2021 Medical Text Analysis

Danielle Smolyar, Research Assistant 3 – Text Analysis for 2.0 LPBI Group’s TNS #1 – 2020/2021 Academic Internship in Medical Test Analysis (MTA)

https://pharmaceuticalintelligence.com/contributors-biographies/research-assistants/danielle-smolyar-research-assistant-3-text-analysis-for-2-0-lpbi-groups-tns-1-2020-2021-academic-internship-in-medical-test-analysis-mta/

7/20: Articles converted to Podcast

https://anchor.fm/danielle-smolyar/episodes/Will-COVID-become-a-disease-of-the-young-e14fao2

https://anchor.fm/danielle-smolyar/episodes/Innovation-massively-expands-view-into-workings-of-single-cells-summary-e14fant

https://anchor.fm/danielle-smolyar/episodes/COVID-and-the-brain-researchers-zero-in-on-how-damage-occurs-e14fao0

4/19: Phase 2 proof of concept Task completion:

chapter 2 

google doc URL:https://docs.google.com/presentation/d/18hSqSbgQQzmJzqgO84od_Mg_yAmnoRXuiZMpUV2WGqc/edit?usp=sharing

Dropbox URL:https://www.dropbox.com/s/yyl8ytoir9u20ir/LPBI_%20Cancer%20Articles%20%28Danielle%29.pdf?dl=0

4/19: Phase 2 proof of concept Tasks Completion: 

chapter 1

google doc URL: https://docs.google.com/presentation/d/1A5gEfMyhxLFdKCmOqMu4FAZO0wnqZmytNGfIPfptfjo/edit?usp=sharing

Dropbox URL:https://www.dropbox.com/s/9ioy9gptese66l8/%20Cancer%20Articles%20chapter%201%20%28Danielle%29.pdf?dl=0

 

2/22: Phase 2 Proof of Concept Tasks Completion:

  • 2/15: Text File for Cancer Volume 1, Chapter 2
  • 2/15.: Biological Images File for Cancer Volume 1, Chapter 2

cloud URL:https://docs.google.com/presentation/d/18hSqSbgQQzmJzqgO84od_Mg_yAmnoRXuiZMpUV2WGqc/edit?usp=sharing

Dropbox URL: https://www.dropbox.com/sh/bnb177hogzd6hwe/AABUzlJmtA-cMPHhVwdBaBK-a?dl=0

 

1/17/20: LPBI Proof of Concept 2.0: Code written by Madison used by Danielle Reference and Visualizations Article title: “LPBI: Proof of Concept Code“ Includes: Tree Diagrams, Hypergraphs, Word Frequency Charts, Word Clouds URL: https://docs.google.com/document/d/1pKQnEvRSceQiyTjDcVmTIYu_GbMmxmon0B9z7siG-3o/edit

 

Article # 1 on PharmaceuticalIntelligence.com

Medical Device Technology for Alzheimer’s Diseases

Reporter: Danielle Smolyar

https://pharmaceuticalintelligence.com/2020/08/20/medical-device-technology-foralzheimers-diseases/

 

PERSONAL PAGE of Danielle Smolyar

List of Projects to be performed in a sequence, upon completion of Project #1, start Project #2, then #3

Project #1: 16 Articles on Cancer – subject to NLP

WordCloud Visualization of LPBI’s Top Sixteen Articles on CANCER in eight categories and by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com

Curator: Stephen J. Williams, PhD and WordCloud Producers: Daniel Menzin, Noam Steiner-Tomer, Zach Day, Ofer Markman, PhD and Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2020/07/30/wordcloud-visualization-of-lpbis-top-sixteen-articles-on-cancer-in-eight-categories-and-by-views-at-all-time-and-their-research-categories-in-the-ontology-of-pharmaceuticalintelligence-com/

 

Project #2: Expand applications of Microsoft AZURE to

Series C: e-Books on Cancer & Oncology

Volume 1:

Cancer Biology and Genomics for Disease Diagnosis

http://www.amazon.com/dp/B013RVYR2K 

Volume 2:

Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery

http://www.amazon.com/dp/B071VQ6YYK 

Project #3: Scaling up NLP, ML, AI to LPBI Group’s FOUR Corpuses

Upon completion of TASK #2, we will engage in task expansion and Scaling up NLP, ML, AI to LPBI Group’s FOUR Corpuses:  PER CONTENT SELECTION by LPBI Group’s Domain Experts 

(1) All 6,000 Journal Articles 

(2) 16 Books in Medicine 

(3) 60 e-Proceedings & 36 Tweet Collections of TOP Global Medical and Biotech Conferences, 2013 – 2020

(4) Content Segmentation by other criteria for Narrow casting the content of the journal ontology, Categories of Research (N = 715). About 70% are related to Drug DIscovery

 

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading…

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,038 other subscribers
  • Recent Posts

    • Novartis and Bristol Myers Squibb halt CAR-T trial for autoimmune diseases over patient deaths: a potential issue with cell-based manufacturing September 15, 2026
    • FDA Contemplates Changes in Trial Design, Drug Development, and Use of AI in Clinical Trials September 15, 2026
    • FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
    • Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
    • In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
    • Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
    • AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
    • In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
    • Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
    • 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d